Lung cancer is the number one cause of cancer-related death in both men and women, killing more Americans each year than colon, breast, and prostate cancers combined. Every year, over 200,000 Americans are diagnosed with lung cancer and about 160,000 die from it.
(American Cancer Society)
What is lung cancer screening?
Until recently, there were no screening tests to find lung cancer early. In 2011, the National Lung Screening Trial proved that low dose computed tomography (LDCT) can find lung cancer at its earliest stages in adults at high risk for lung cancer. The National Lung Screening Trial showed 20 percent fewer lung cancer deaths in study subjects who were screened with LDCT, making LDCT the first and only cost-effective screening test shown to reduce lung cancer deaths.
LDCT is a CT scan that uses a low dose of radiation to find lung nodules, some of which may be cancer. Lung cancer screening with LDCT is for people who have no lung cancer symptoms but who are at high risk of lung cancer because of a heavy smoking history. Lung cancer screening is not a single test, but a series of annual screenings and follow-up over time. It is a process that must be done correctly under the direction of your health care provider. Screening may not find all lung cancers. But research shows that if people at high risk have this test every year, they're less likely to die from lung cancer.
Lung Cancer Screening at Exeter Hospital
Exeter Hospital’s Lung Cancer Screening Program provides lung cancer screening to adults who meet the high risk criteria. We follow national, research-based standards to deliver coordinated care and ongoing follow-up. Our team includes:
- Specialist physicians who are board-certified in radiology, pulmonary medicine, surgery and oncology.
- CT scan technologists who are expert in high quality, low-dose CT imaging techniques.
- The program navigator who coordinates communication and follow-up.